SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Steroidogenesis Inhibitors (STGI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bert Klimer who started this subject12/18/2001 6:59:43 PM
From: Jim Burnham  Read Replies (1) of 294
 
Some history and my foresight.

The price used to be $5 and now it is $0.14. What could cause that?

In my opinion, it is a number of factors.

One, during the time when Sapse was in control of the company and the
stock was at $5, SEC filings weren't made on time and the company was
delisted, sending the price down to $2.

Two, Sapse resigned and lawsuits were filed against SPHC. I wonder if he resigned because
the stock went from $5 to $2?

Three, since the lawsuits involved shareholders of SPHC, it is only natural that some people
would sell their stock.

Four, the market tanked and hard.

Five, ever heard of tax selling?

Six, historically, penny stocks drop at this time of year. Don't expect any general upswings in
price until January.

Now, go look at the chart two years ago. We sunk to $0.50. At that time we had Anticort and
that is it. And within 5 months we hit $5.00 at which point we had... Anticort.

Now, the FDA trials are further along. There is a wealth of new scientific experience in the
company. A $25 million line of credit. 6, count them, 6 patents. 3 lawsuit wins.

Of course, there has been some dilution, so for estimation purposes figure the old $5.00 price
as $2.50. You make the call.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext